Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held On

By Department of Health and Human Services

Book Id: WPLBN0000002051
Format Type: PDF eBook
File Size: 0.4 MB
Reproduction Date: 2005

Title:	Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held On
Author:	Department of Health and Human Services
Volume:
Language:	English
Subject:	Health., Medical research, Medical reports
Collections:	Medical Library Collection
Historic Publication Date:
Publisher:	Centers for Disease Control and Prevention


Citation APA MLA Chicago Health And Human Services, D. O. (n.d.). Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held On. Retrieved from http://gutenberg.cc/

Excerpt
Agenda Item Purpose/Action Presider/Presenter(s) October 17 8: 30 Welcome Dr. J. Modlin (Chair, ACIP) Disclosure by Committee Members Dr. D. Snider (CDC, OD) 9: 15 Report of the Rotavirus Vaccine and Information Dr. S. Katz (Duke Univ.) intussusception working group Dr. M. Levin (Univ. of Colorado) Dr. G. Peter (NVAC) 10: 00 BREAK 10: 30 Issues related to Influenza Vaccine Information Dr. K. Fukuda (NCID, DVRD) Burden of influenza Discussion Dr. K. Midthun (FDA, CBER) Summary of VRBPAC / possible time Dr. K. Neuzil (Univ. of Wash) frame for LAIV Dr. K. Nichol (VA) Summary of TIV safety and efficacy Dr. B. Schwartz (NIP, ESD) Summary of feasibility/implementation issues Dr. N. Smith (CA Dept. of Hlth) Summary of program funding issues Dr. T. Uyeki (NCID, DVRD) Dr. B. Word (ACIP) 12: 15 Update on 2001-2002 influenza vaccine supply Information Mr. D. O’Mara (NIP, ISD) 12: 30 LUNCH 1: 30 Hepatitis B Recommendation Discussion Dr. H. Margolis (NCID,DVRD) Decision/Vote Dr. Wm. Schaffner (Vanderbilt) Dr. J. Siegel (Univ. of Texas) 2: 30 Inclusion of Twinrix in the VFC Program VFC Vote Dr. M. Wharton (NIP, ESD) 2: 45 Childhood Harmonized Immunization Schedule Discussion Dr. M. Cortese (NIP, ESD) Decision Dr. N. Smith (CA Dept Public Hlth.) 3: 30 BREAK 4: 00 Adult Harmonized Schedule Information Dr. B. Schwartz (NIP, ESD) Discussion Dr. V. Sneller (NIP, ESD) 4: 45 Use of OPV to Control Outbreaks of Information Dr. B. Schwartz (NIP, ESD) Poliomyelitis 5: 15 IOM Recommendations on Thimerosol Discussion Dr. M. McCormick (IOM) Dr. K. Stratton (IOM)...

Table of Contents
TABLE OF CONTENTS Meeting Attendance MINUTES OF THE MEETING OCTOBER 17, 2001 OPENING COMMENTS/DISCLOSURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 COMMITTEE BUSINESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 NVPO/NVAC WORKSHOP: ROTAVIRUS VACCINE AND INTUSSUSCEPTION . . 2 ISSUES RELATED TO INFLUENZA VACCINE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Influenza disease burden among children . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Use of TIV Vaccine in Children . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Economic Studies of Influenza Vaccination . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Implementation Challenges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Economic Analysis of NIP Impact . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 VRBPAC Perspective. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Issues related to universal influenza immunization . . . . . . . . . . . . . . . . . . . . . . . 20 Influenza Vaccine Production Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 HEPATITIS B RECOMMENDATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Inclusion of the Twinrix™ hepatitis vaccine in the VFC program. . . . . . . . . . . 28 REVIEW: HARMONIZED CHILDHOOD IMMUNIZATION SCHEDULE . . . . . . . . 29 ADULT IMMUNIZATION SCHEDULE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 USE OF OPV FOR OUTBREAK CONTROL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 IOM RECOMMENDATION ON THIMEROSAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Workgroup Recommendations to the Acip . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 PUBLIC COMMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 OCTOBER 18, 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 THIMEROSAL-CONTAINING VACCINES WORKGROUP REPORT . . . . . . . . . . . 45 AGENCY UPDATES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 PROPOSAL TO DECREASE THE TIME INTERVAL RECOMMENDED TO AVOID PREGNANCY AFTER RECEIPT OF RUBELLA VACCINE . . . . . . . . . . . . . 52 UPDATE ON PNEUMOCOCCAL CONJUGATE VACCINE . . . . . . . . . . . . . . . . . . . 55 Wyeth-Lederle Perspective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 VARICELLA DISEASE/VACCINE UPDATE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 Immunogenicity of Varivax® and Breakthrough Disease . . . . . . . . . . . . . . . . . 62 Surveillance Data: Varicella and Herpes Zoster . . . . . . . . . . . . . . . . . . . . . . . . . 63 IMPLICATION TO CHILDHOOD IMMUNIZATION DELIVERY FROM OSHA REQUIREMENTS FOR SAFETY ENGINEERED NEEDLES . . . . . . . . . . . . . 66 ADAPTATION OF A VACCINE FORMULARY SELECTION ALGORITHM TO A WEB-ACCESSIBLE TOOL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71